Pig-to-Human xenotransplantation: Moving toward organ customization.

Precis Clin Med

Transplant Center, Key Laboratory of Transplant Engineering and Immunology, Institute of Clinical Pathology, West China Hospital, Sichuan University, Chengdu 610041, China.

Published: June 2023


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266333PMC
http://dx.doi.org/10.1093/pcmedi/pbad013DOI Listing

Publication Analysis

Top Keywords

pig-to-human xenotransplantation
4
xenotransplantation moving
4
moving organ
4
organ customization
4
pig-to-human
1
moving
1
organ
1
customization
1

Similar Publications

Pig-to-human lung xenotransplantation into a brain-dead recipient.

Nat Med

August 2025

Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Research Centre for Respiratory Disease, Guangzhou, China.

Article Synopsis
  • The first successful transplant of genetically engineered pig lungs into a human was performed on a 39-year-old brain-dead male, raising important questions about immune response and organ rejection in xenotransplantation.
  • The lung from a six-gene-edited pig functioned well for 216 hours post-transplant without hyperacute rejection or infection, although it experienced severe edema and antibody-mediated rejection later on.
  • Immunosuppression protocols were used to manage the recipient's immune response, highlighting the ongoing challenges of organ rejection and infection before xenotransplantation can become a standard clinical practice.
View Article and Find Full Text PDF

Over the past 40 years, the pig-to-nonhuman primate organ transplantation model has enabled progress in xenotransplantation to be made to the point that we are now carrying out initial US FDA-approved clinical experiments on "compassionate" grounds. More recently, the pig-to-human brain-dead decedent model was introduced with claims that this might replace (or at least augment) the pig-to-NHP model. There are, however, several limitations of the decedent model, most notably the very limited period during which the subject may remain sufficiently metabolically and hemodynamically stable to allow meaningful monitoring of the fate of a pig organ graft.

View Article and Find Full Text PDF

Bioartificial liver: Where lies the path ahead-A review.

Hepatol Commun

September 2025

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhej

Despite its proven effectiveness in treating liver failure, liver transplantation is often impractical due to its high surgical risks involved and the limited availability of donor organs. Blood purification technologies used in non-bioartificial liver (NBAL) systems have improved clinical cure rates, but they do not substitute for the complex biosynthesis, detoxification, metabolism, and biological transformation roles of the liver. To overcome these challenges brought by NBAL systems, bioartificial liver (BAL) systems have been developed with repeated optimization of both hepatocyte sources and bioreactors to emulate a "fully functional liver".

View Article and Find Full Text PDF

Recent advancements in genetically engineered pigs have spurred research into pig-to-human xenotransplantation, particularly involving heart, kidney and liver. Here we characterize immune cell populations cells in both peripheral blood and transplanted liver in a human decedent who received a pig liver xenograft and who was monitored over the course of 10 days. Using single-cell RNA sequencing and spatial RNA sequencing, we found that T cells were progressively activated in the peripheral blood, whereas γδT cells and exhausted T cells infiltrated the pig liver extensively, indicating impaired adaptive immunity.

View Article and Find Full Text PDF